Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2022-08-10 Earnings Release
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Earnings Release 2022
Earnings Release Classification · 100% confidence The document explicitly announces 'Financial Results for the First Half of 2022' and contains detailed financial tables, including 'CONSOLIDATED KEY FIGURES' for the '6 Months Ended June 30, 2022'. It presents comprehensive financial statements like Statements of Comprehensive Income, Balance Sheets, and Statements of Cash Flows for the six-month period. This structure and content strongly indicate a comprehensive financial report covering a period shorter than a full year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it is a comprehensive report, not just highlights, and it is not a 10-K as it covers only six months. H1 2022
2022-08-10 English
Genmab Announces Financial Results for the First Half of 2022
Report Publication Announcement Classification · 95% confidence The document is a press release announcing the financial results for the first half of 2022. While it contains summary financial data and highlights, it explicitly directs the reader to an attached file titled '100822_CA41_Genmab Q2 2022 Interim Report' for the full report. According to the 'Menu vs Meal' rule, a document that announces the publication of a report and provides a link or attachment to the full version is classified as a Report Publication Announcement (RPA). H1 2022
2022-08-10 Danish
6-K
Foreign Filer Report
2022-08-08 English
Earnings Release 2022
Earnings Release Classification · 98% confidence The document is a 'Company Announcement' from Genmab dated August 8, 2022, where the company explicitly states it is 'improving its 2022 financial guidance' previously published on May 11, 2022. It provides revised figures for revenue, operating expenses, and operating profit for the full year 2022. This type of announcement, which releases preliminary or updated financial expectations outside of the formal quarterly or annual report filing, is best classified as an Earnings Release (ER), as it focuses on key financial highlights and guidance updates. It is not a full Interim Report (IR) or Annual Report (10-K), nor is it a transcript (CT) or a formal presentation (IP). Since it is an initial release of updated financial expectations, ER is the most appropriate code. H1 2022
2022-08-08 English
Genmab Improves Its 2022 Financial Guidance
Earnings Release Classification · 95% confidence The document is a company announcement titled 'Genmab Improves Its 2022 Financial Guidance'. It provides updated financial projections for revenue, operating expenses, and operating profit. While it contains financial data, it is an announcement of a guidance update rather than a full quarterly or annual report. It does not fit the criteria for a full Earnings Release (ER) as it focuses specifically on a guidance revision, and it is not a report publication announcement (RPA) because it contains the actual content of the guidance update rather than just announcing the availability of a report. Therefore, it is best classified as a Regulatory Filing (RNS) as it is a standard corporate announcement regarding financial outlook. FY 2022
2022-08-08 Danish
6-K
Foreign Filer Report
2022-08-08 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.